Table 6.
JAAM DIC (n = 395) | Non-DIC (n = 1565) | P value | Missing data (%) | |
---|---|---|---|---|
Age (years) | 59.84 ± 16.84 | 66.95 ± 16.39 | <0.0001 | 0 |
Gender (male/female) | 214/181 | 925/640 | 0.0790† | 0.03 |
JAAM DIC score | 4.74 ± 1.22 | 1.26 ± 0.52 | <0.0001 | 13.16†† |
Platelet count (× 10^9/l) | 103.98 ± 101.56 | 224.83 ± 132.03 | <0.0001 | 0.1 |
Prothrombin time (seconds) | 16.28 ± 4.2 | 15.67 ± 4.85 | 0.0125 | 1.48 |
Prothrombin time ratio | 1.87 ± 1.24 | 1.7 ± 1.05 | 0.0122 | 2.45 |
Fibrinogen (g/l) | 4.4 ± 2.44 | 4.38 ± 2.1 | 0.9139 | 61.94 |
FDP (mg/l) | 91.81 ± 181.01 | 53.48 ± 152.85 | 0.0624 | 83.21 |
SIRS score | 2.42 ± 0.67 | 2.37 ± 0.66 | 0.1720 | 0 |
SAPS I score | 16.82 ± 5.5 | 16.31 ± 5.19 | 0.1093 | 9.03 |
SOFA score | 10.72 ± 4.61 | 8.27 ± 3.89 | <0.0001 | 0 |
MODS (%) | 41.5% | 22.4% | <0.0001 | 0 |
28-day mortality (%) | 44.1% | 27.5% | <0.0001 | 0 |
1-year mortality (%) | 59.7% | 49.1% | 0.00013 | 0 |
The count of patients add up not to the number of total eligible patients in the study, but only to the number of patients whose DIC status was known on day 1, that is, 13.16% less than all eligible patients.
From a t-test comparing the proportion of male/female between the two groups.
This cell differs from the others in the column because here the denominator is the number of eligible patients, rather than the number of eligible patients with known DIC status.